All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Stated-preference study to examine the economic value of benefits of avoiding selected adverse human health outcomes due to exposure to chemicals in the European Union: Part III: Carcinogens

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11690%2F14%3A10294057" target="_blank" >RIV/00216208:11690/14:10294057 - isvavai.cz</a>

  • Result on the web

    <a href="http://echa.europa.eu/documents/10162/13630/study_economic_benefits_avoiding_adverse_health_outcomes_3_en.pdf" target="_blank" >http://echa.europa.eu/documents/10162/13630/study_economic_benefits_avoiding_adverse_health_outcomes_3_en.pdf</a>

  • DOI - Digital Object Identifier

Alternative languages

  • Result language

    angličtina

  • Original language name

    Stated-preference study to examine the economic value of benefits of avoiding selected adverse human health outcomes due to exposure to chemicals in the European Union: Part III: Carcinogens

  • Original language description

    Stated-preference study to examine the economic value of benefits of avoiding selected adverse human health outcomes due to exposure to chemicals in the European Union: Part III: Carcinogens The primary objective of this stated-preference study was to estimate willingness to pay to avoid selected adverse human health outcomes due to exposure to chemicals in the European Union and to derive representative EU-wide benefit estimates reference values. The results are intended for use by ECHA and other bodies when carrying out socio-economic analyses or health impact assessments in connection to REACH Regulation. This report focuses on health outcomes linked to carcinogens, particularly to cancer risks. Each health outcome that is valued in this study was selected based on a comprehensive literature review, consultations with epidemiologists and medical experts and in close cooperation with ECHA.

  • Czech name

  • Czech description

Classification

  • Type

    V<sub>souhrn</sub> - Summary research report

  • CEP classification

    AH - Economics

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    N - Vyzkumna aktivita podporovana z neverejnych zdroju

Others

  • Publication year

    2014

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Number of pages

    124

  • Place of publication

  • Publisher/client name

    European Chemicals Agency

  • Version